ValueQ4, 24TTMSelling/general/admin expenses——Research & development——Operating income——Non-Operating Income, Total——Interest expense, net of interest capitalized——Non-Operating Income, excl. Interest Expenses——Unusual income/expense——Pretax income——Equity in earnings——Taxes——Non-controlling/minority interest——After tax other income/expense——Net income before discontinued operations——Discontinued operations——Net income——Dilution adjustment——Preferred dividends——Diluted net income available to common stockholders——Basic earnings per share (Basic EPS)——Diluted earnings per share (Diluted EPS)——Average basic shares outstanding——Diluted shares outstanding——EBITDA——EBIT——Cost of revenue——Other cost of goods sold——Depreciation & amortization (cash flow)——
Evogene Ltd
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.